Tirzepatide for Obesity Treatment and Diabetes Prevention.

已完结 10 由 YYYY 发布于 2025/9/15 18:05:35

DOI:10.1056/NEJMoa2410819
作者：Ania M Jastreboff,?Carel W le Roux,?Adam Stefanski,?Louis J Aronne,?Bruno Halpern,?Sean Wharton,?John P H Wilding,?Leigh Perreault,?Shuyu Zhang,?Ramakrishna Battula,?Mathijs C Bunck,?Nadia N Ahmad,?Ir
文献类型：期刊论文
补充材料：只需要正文

New England Journal of Medicine (NEJM)

Abstract：Background: Obesity is a chronic disease and causal precursor to myriad other conditions, including type 2 diabetes. In an earlier analysis of the SURMOUNT-1 trial, tirzepatide was shown to

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Taylor & FrancisIntranasal delivery of doxepin: enhancing brain targeting efficiency utilizing nanostructured lipid carriers for a biopharmaceutics drug disposition classification system class-I drug.